Celyad

celyad logo
Celyad

Stories by Celyad

CAR-T NKR2: leveraging the breadth of innate immunity

This paper describes the technology and early clinical development of the CAR T NKR-2 platform and elucidates its fundamental differences with classical CAR-T technologies, that could reshape the frontiers of cell-based cancer immunotherapy.